AIP
AURA icon

Ameritas Investment Partners’s Aura Biosciences AURA Stock Holding History

Ameritas Investment Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.4K Hold
4,544
– – ﹤0.01% 2380
2025
Q4 		$24.8K Hold
4,544
– – ﹤0.01% 2533
2025
Q3 		$28.1K Hold
4,544
– – ﹤0.01% 2515
2025
Q2 		$28.4K Hold
4,544
– – ﹤0.01% 2503
2025
Q1 		$26.6K Hold
4,544
– – ﹤0.01% 2426
2024
Q4 		$37.4K Hold
4,544
– – ﹤0.01% 2353
2024
Q3 		$40.5K Hold
4,544
– – ﹤0.01% 2313
2024
Q2 		$34.4K Buy
4,544
+2,276
+100% +$16.7K ﹤0.01% 2344
2024
Q1 		$17.8K Hold
2,268
– – ﹤0.01% 2601
2023
Q4 		$20.1K Hold
2,268
– – ﹤0.01% 2581
2023
Q3 		$20.3K Hold
2,268
– – ﹤0.01% 2528
2023
Q2 		$28K Buy
2,268
+894
+65% +$9.56K ﹤0.01% 2375
2023
Q1 		$12.8K Hold
1,374
– – ﹤0.01% 2634
2022
Q4 		$14.6K Hold
1,374
– – ﹤0.01% 2676
2022
Q3 		$24K Hold
1,374
– – ﹤0.01% 2422
2022
Q2 		$19K Buy
1,374
+953
+226% +$15.8K ﹤0.01% 2556
2022
Q1 		$9K Hold
421
– – ﹤0.01% 2823
2021
Q4 		$7K Buy
+421
New +$7.52K ﹤0.01% 2978

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameritas Investment Partners's AURA Position: Q1 2026 in Review

Ameritas Investment Partners held its Aura Biosciences (AURA) position steady in Q1 2026 at 4,544 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Ameritas Investment Partners first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $40.5K in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Ameritas Investment Partners held 4,544 shares of Aura Biosciences worth $30.4K as of Q1 2026.
  • Ameritas Investment Partners left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2380 holding.
  • Ameritas Investment Partners first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Ameritas Investment Partners's Aura Biosciences position peaked at $40.5K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.